CryoPort, Inc. (CYRX)

NASDAQ: CYRX · IEX Real-Time Price · USD
24.94
1.85 (8.01%)
May 27, 2022 11:46 AM EDT - Market open
Market Cap1.23B
Revenue (ttm)221.63M
Net Income (ttm)-293.41M
Shares Out49.38M
EPS (ttm)-6.19
PE Ration/a
Forward PE131.58
Dividendn/a
Ex-Dividend Daten/a
Volume84,668
Open23.33
Previous Close23.09
Day's Range23.33 - 24.94
52-Week Range19.82 - 86.30
Beta1.28
AnalystsBuy
Price Target54.29 (+117.7%)
Earnings DateMay 5, 2022

About CYRX

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the...

IndustryHealth Care Equipment & Supplies
Founded1999
Employees850
Stock ExchangeNASDAQ
Ticker SymbolCYRX
Full Company Profile

Financial Performance

In 2021, CryoPort's revenue was $222.61 million, an increase of 182.87% compared to the previous year's $78.70 million. Losses were -$275.53 million, 742.8% more than in 2020.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for CYRX stock is "Buy." The 12-month stock price forecast is 54.29, which is an increase of 117.68% from the latest price.

Price Target
$54.29
(117.68% upside)
Analyst Consensus: Buy
Stock Forecasts

News

CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

Cryoport Reports First Quarter 2022 Results

Revenue of $52.3 million Provides Full Year 2022 Revenue Guidance of $260-$265 million Expansion and advancement of robust clinical pipeline continues – now supporting a record 609 clinical trials, with...

3 weeks ago - PRNewsWire

Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022

NASHVILLE, Tenn. , April 28, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...

4 weeks ago - PRNewsWire

Cryoport Acquires Cell&Co BioServices

Acquisition of Cell&Co BioServices, Clermont-Ferrand, France, accelerates Company's EMEA expansion plans and development of its Global Supply Chain Network NASHVILLE, Tenn. , April 18, 2022 /PRNewswire/...

1 month ago - PRNewsWire

Cryoport's MVE Biological Solutions' New Prague Manufacturing Plant Returns to Full Production

Company provides further update on financial impact of New Prague, MN fire NASHVILLE, Tenn., March 30, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader i...

1 month ago - PRNewsWire

Cryoport Authorizes $100 Million Repurchase Program

Management Presenting at Upcoming Investor Conferences NASHVILLE, Tenn., March 11, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-contro...

2 months ago - PRNewsWire

New Strong Sell Stocks for March 10th

BSET, CYRX, and DIN have been added to the Zacks Rank #5 (Strong Sell) List on March 10, 2022.

Other symbols:BSETDIN
2 months ago - Zacks Investment Research

CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -780% and 2.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Cryoport Reports Fourth Quarter and Full Year 2021 Results

NASHVILLE, Tenn., Feb. 24, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

3 months ago - PRNewsWire

Here's Why CryoPort, Inc. (CYRX) is Poised for a Turnaround After Losing 22.8% in 4 Weeks

CryoPort, Inc. (CYRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revis...

3 months ago - Zacks Investment Research

CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Cryoport Report's Fourth Quarter and 2021 Financial Results on February 24, 2022

NASHVILLE, Tenn., Feb. 15, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

3 months ago - PRNewsWire

Cryoport Provides Positive Update on MVE Biological Solution's New Prague Facility

NASHVILLE, Tenn., Feb. 9, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industr...

3 months ago - PRNewsWire

Cryoport Reports Fire Damage at MVE's New Prague Facility

NASHVILLE, Tenn., Jan. 31, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

3 months ago - PRNewsWire

Cryoport and Cell Matters Enter into Strategic Partnership

NASHVILLE, Tenn., Jan. 27, 2022 /PRNewswire/ --  Cryoport, Inc.  (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...

4 months ago - PRNewsWire

Cryoport to Present at the J.P. Morgan 40th Annual Healthcare Conference

NASHVILLE, Tenn., Jan. 5, 2022 /PRNewswire/ -- Cryoport, Inc.  (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

4 months ago - PRNewsWire

Cryoport, Inc. Prices Upsized $350.0 Million Convertible Senior Notes Offering

NASHVILLE, Tenn., Nov. 9, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the pricing...

6 months ago - PRNewsWire

Cryoport, Inc. Prices Registered Direct Placement of Common Stock

NASHVILLE, Tenn., Nov. 9, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the pricing...

6 months ago - PRNewsWire

Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering

NASHVILLE, Tenn., Nov. 8, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced its intenti...

6 months ago - PRNewsWire

Cryoport, Inc. Announces Proposed Registered Direct Placement of Common Stock

NASHVILLE, Tenn., Nov. 8, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced its intenti...

6 months ago - PRNewsWire

CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -20.00% and 3.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Recap: CryoPort Q3 Earnings

CryoPort (NASDAQ:CYRX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

6 months ago - Benzinga

Cryoport Reports Record Third Quarter and Nine Months Revenue for 2021

NASHVILLE, Tenn., Nov. 4, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industr...

6 months ago - PRNewsWire

CRYOPDP, a Cryoport Company, Receives 2021 Europe Bioprocessing Excellence Award from IMAPAC

NASHVILLE, Tenn., Oct. 29, 2021 /PRNewswire/ --  Cryoport, Inc.  (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...

6 months ago - PRNewsWire

CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research